TEAS for Chronic Constipation
Trial Summary
What is the purpose of this trial?
Transcutaneous electrical acupoint stimulation (TEAS) is an emerging technology for non-invasive neuromodulation that has broad potential implications and warrants further study. The investigators' clinical experience from the University of California, Los Angeles (UCLA) Center for East-West Medicine (CEWM) has also demonstrated that TEAS can be used as an effective self-care tool for patients with chronic illness who do not have the time or resources for frequent acupuncture treatments. Chronic constipation is the chosen area of study because of the large population with a substantial impairment in health-related quality of life and work productivity. The investigators have recently completed a randomized controlled trial (RCT) demonstrating the benefit of perineal self-acupressure on quality of life measurements in this population, which supports investigation into other acupuncture-based self-care interventions. Given these findings, the investigators hypothesize that home patient-administered TEAS can provide measurable improvements in both symptom severity and health related quality of life.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you've changed your constipation-related medications in the past month or use rescue medications more than once a week.
What data supports the effectiveness of the treatment TEAS for chronic constipation?
Research shows that transcutaneous electrical nerve stimulation (TENS) at acupoints can improve symptoms and increase colonic transit in patients with slow transit constipation. Additionally, transcutaneous electrical acustimulation (TEA) at acupoint ST36 has been found effective for treating chronic constipation, with sustained benefits.12345
Is TEAS safe for humans?
Research shows that transcutaneous electrical acupoint stimulation (TEAS) is generally safe for treating conditions like chronic constipation and pain management after surgery. It is a non-invasive treatment, meaning it doesn't involve surgery or entering the body, and studies have not reported significant safety concerns.12346
How is the TEAS treatment different from other treatments for chronic constipation?
Research Team
Andrew Shubov, MD
Principal Investigator
University of California, Los Angeles
Eligibility Criteria
This trial is for adults over 18 with chronic constipation, meeting specific criteria like straining or hard stools during bowel movements. They must not have numbness in certain areas, bladder issues, recent weight loss, or use of frequent laxatives. Participants need normal blood tests and can't have a pacemaker or similar devices.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a bowel movement logbook and submit surveys, with HRV measurement and instruction on TEAS pad placement
Treatment
Participants use TEAS device daily for 30 minutes, track device use and bowel movements, and complete weekly online surveys
Follow-up
Participants return devices and repeat surveys and HRV measurements
Treatment Details
Interventions
- Sham TEAS
- Transcutaneous Electrical Acupoint Stimulation (TEAS)
- Verum TEAS
Transcutaneous Electrical Acupoint Stimulation (TEAS) is already approved in United States, European Union, China for the following indications:
- Chronic Constipation
- Pain Management
- Neuromodulation
- Chronic Constipation
- Pain Relief
- Neurological Disorders
- Chronic Constipation
- Pain Management
- Digestive Disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor